German Remedies Pharmaceuticals Private Limited
German Remedies Pharmaceuticals Private Limited is a Private Non-govt company company incorporated in 2010 and based in Gujarat, India. German Remedies Pharmaceuticals Private Limited operates in Manufacture of pharmaceuticals, medicinal chemicals and botanical products (NIC 24230) with authorized capital of ₹70.00 Cr and paid-up capital of ₹66.83 Cr. For 2023-24, the company reported revenue of ₹490.74 Cr and profit after tax of ₹50.07 Cr. The board has 2 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
GERMAN REMEDIES PHARMACEUTICALS PRIVATE LIMITED is the legal entity of German Remedies.
Quick facts
Directors
2 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 26 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +4d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +38d | filed |
| MGT-7 | FY2022-23 | 23 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for German Remedies Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 903476719 | HDFC Bank Ltd(Bank) | ₹9.41 Cr | 04 Jul 2020 | Satisfied |
| 844961796 | ICICI Bank Ltd(Bank) | ₹20.84 Cr | 19 Sep 2021 | Satisfied |
| 748297305 | ICICI Bank Ltd(Bank) | ₹14.43 Cr | 12 Mar 2019 | Satisfied |
| 146323026 | State Bank of India(Bank) | ₹9.58 Cr | 27 Jan 2019 | Open |
Charge IDs, lenders & amounts for German Remedies Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — |
Detailed Financials
4 FYs| Line item | 2023-24 | 2022-23 | 2021-22 | 2020-21 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | +2.0% | +8.0% | +613.0% | |
| Profit after Tax2023-24 | +60.0% | +6.0% | — | |
| Net Worth2023-24 | +43.0% | +17.0% | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2016-17 | -179.77% | — | — | -22.45% | — | |||
| 2017-18 | -70.50% | +80.58% | — | -16.45% | — | |||
| 2018-19 | +12.30% | +147.31% | — | +5.72% | — | |||
| 2020-21 | +11.23% | +1527.92% | +31.25% | +20.41% | 0.53 | |||
| 2021-22 | +11.43% | +18.37% | +27.35% | +18.91% | 0.45 | |||
| 2022-23 | +8.02% | +9.30% | +17.34% | +12.43% | 0.40 | |||
| 2023-24 | +10.20% | +1.64% | +18.30% | +13.87% | 0.32 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 1,41,63,048 | 56.01% |
| Institutional Investors | 1 | 25,45,162 | 10.07% |
| Public & Others | 45 | 85,77,160 | 33.92% |
Promoter, institutional & public holding for German Remedies Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
41 peersTop 10 in Manufacture of pharmaceuticals, medicinal chemicals and botanical products
by healthView all ›Events & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.